Studies in which VEGF-A, VEGF-C, FGF-2 or other growth factors in this setting are blocked might answer the question of relative importance of one or more of these factors alone or in concert and could be important for further cancer treatment approaches. The gene discussed is FGF2; the disease is cancer.